Roman Chlíbek

Medicine · Health Sciences

23h-index4.5kcitations130works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(30), Hepatitis B Virus Studies(12), Poxvirus research and outbreaks(12), Pneumonia and Respiratory Infections(11), Hepatitis Viruses Studies and Epidemiology(11)

Publications130 total

Overcoming barriers to adult immunization in Europe: A decalogue for policy action by the Adult Immunization Board
Health Policy and Technology·2026Open Access
Prevalence of Borrelia burgdorferi sensu lato infection in the Czech Republic
International Journal of Medical Microbiology·2025· 1 citedOpen Access
Tick-Borne Encephalitis Vaccination
2025
Jak se mění epidemiologie rotavirových nákaz v souvislosti s očkováním v České republice
Epidemiologie mikrobiologie imunologie·2025
Prevalence of Borrelia Burgdorferi Sensu Lato Infection in the Czech Republic
SSRN Electronic Journal·2024Open Access
Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response
Journal of Virological Methods·2023· 6 cited
Intracerebral haemorrhage in COVID-19
Česká a slovenská neurologie a neurochirurgie·2022
The future of Covid-19 vaccination
Hygiena·2022Open Access
Experience with the treatment of cryptococcal meningitis
Česká a slovenská neurologie a neurochirurgie·2022
Vaccination of cancer patients
Onkologie·2022
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries
Vaccine·2021· 15 citedOpen Access
Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
The Journal of Infectious Diseases·2020Open Access
Epidemiology of vancomycin-resistant enterococci in the Hradec Králové University Hospital in 2017.
PubMed·2020
Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials
Vaccine·2019· 27 citedOpen Access
Chronic hepatitis C in the Czech Republic: Forecasting the disease burden
Central European Journal of Public Health·2019· 4 citedOpen Access
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
Human Vaccines & Immunotherapeutics·2019· 48 citedOpen Access
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
Vaccine·2019· 61 citedOpen Access
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial
The Lancet Infectious Diseases·2019· 43 cited
In-vivo interspecies transmission of carbapenemase KPC in a long-term treated female patient.
PubMed·2019· 1 cited
Prevalence of hepatitis C virus infection in adults with the risk factors.
PubMed·2019· 2 cited
page 1 of 7Next →

Frequent Co-authors

Jan Smetana(19), Roman Prymula(19), Thomas C. Heineman(11), Vytautas Usonis(11), Himal Lal(9), Karlis Pauksens(9), Miroslav Špliňo(9), Atanas Mangarov(9), Zsófia Mészner(9), Pavol Šimurka(8), Eda Tamm(8), Anthony L. Cunningham(7), Shinn‐Jang Hwang(7), Myron J. Levin(7), Janet E. McElhaney(7), Tino F. Schwarz(7), Ioana Anca(7), Francis André(7), Darko Richter(7), Nuran Salman(7)